
Outlook Therapeutics Inc (OTLK)
NASDAQ
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -180.135 | -223.256 | -182.861 | -265.13 | -249.92 | -257.317 | -193.931 | -246.604 |
Return on Equity (%) | 206.049 | 162.237 | 172.962 | 734.782 | -1430.459 | -989.988 | 2069.216 | 172.238 |
Return on Invested Capital (%) | 294.989 | 133.657 | 167.433 | 1238.293 | -610.626 | -566.506 | 1340.226 | 159.672 |
Operating Margin (%) | -858.395 | -966.613 | -423.128 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | -1050 | -1555.019 | -442.426 | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | -1.35 | -0.288 | -0.376 | 0.022 | 0.026 | 0.038 | -0.055 | -2.934 |
Earnings Per Share | -1.605 | -0.665 | -1.26 | -0.384 | -0.301 | -0.291 | -0.227 | -3.026 |
Cash Per Share | 0.128 | 0.024 | 0.28 | 0.099 | 0.082 | 0.077 | 0.09 | 0.599 |
Working Capital Per Share | -0.996 | -0.398 | -0.237 | 0.016 | 0.084 | 0.034 | -0.061 | -0.608 |
Operating Profit Per Share | 0.153 | 0.043 | 0.285 | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.538 | -0.467 | -1.326 | -0.303 | -0.301 | -0.291 | -0.227 | -3.026 |
EBITDA Per Share | -1.538 | -0.467 | -1.326 | -0.303 | -0.301 | -0.291 | -0.227 | -3.026 |
Free Cash Flow Per Share | -1.702 | -0.669 | -1.362 | -0.386 | -0.302 | -0.291 | -0.227 | -3.026 |
Fin d'année 30 Septembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 24,93M | 72,22M | 28,61M | 127,18M | 176,46M | 227,31M | N/A | 24,91M |
Fin d'année 30 Septembre 2024 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 | Déc 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | N/A | N/A | N/A | N/A | N/A | 24,91M | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 44,82M |
Ratio cours/bénéfice | -0,56 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 2,83 |
Ratio prix/valeur comptable | -0,58 |
Rendement de dividende | - |
Actions en circulation | 32,02M |
Volume moyen (1 semaine) | 620,62k |
Volume moyen (1 mois) | 429,19k |
Variation sur 52 semaines | -85,94% |
Plus haut sur 52 semaines | 12,8499 |
Plus bas sur 52 semaines | 0,87 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales